• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

FUJIFILM Sonosite & the CHEST Foundation Partner for COVID-19 Research

by Jasmine Pennic 09/15/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Fujifilm Sonosite Unveils Next-Gen Point-of-Care Ultrasound System for Frontline Clinicians

What You Should Know:

– FUJIFILM Sonosite, Inc. today announced their partnership with the CHEST Foundation, the charitable foundation of the American College of Chest Physicians, on the CHEST Foundation COVID-19 Research Grant program. 

– To support this program, FUJIFILM Sonosite is contributing $70,000 to the foundation and will donate newly launched Sonosite PX ultrasound systems to the selected research award sites.


FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound (POCUS) solutions, and the CHEST Foundation, the charitable foundation of the American College of Chest Physicians, today announced their joint grant in creating the CHEST Foundation Research Grant in Ultrasonography and COVID-19. 

The objective of the grant is to investigate the role of POCUS technology on COVID-19 patients through clinical research.  FUJIFILM Sonosite is contributing up to 2 grants of $30,000 to the CHEST Foundation in support of the joint program and will also donate newly launched Sonosite PX ultrasound systems to the selected research award sites.

As of early-September 2020, COVID-19 has resulted in more than 27 million infections and 898,000 deaths across the world. Although early studies report that POCUS is providing numerous benefits to intensive care clinicians caring for COVID-19 patients, additional research on the efficacy in the management of this deadly virus is critical.

“COVID-19 continues to negatively affect the health of people around the globe and overwhelm health care systems,” said Diku Mandavia, MD, FACEP, Senior Vice President, Chief Medical Officer of FUJIFILM Sonosite. “As a company that is focused on providing innovative, point of care ultrasound technology to healthcare providers, we’re excited to host a joint grant with the CHEST Foundation. This research grant will investigate how POCUS can help in COVID-19 ICU care and has the potential to build upon the current evidence.”

The FUJIFILM Sonosite and CHEST Foundation Research Grant in Ultrasonography and COVID-19 is currently open and accepting proposals from interested CHEST medicine professionals and members in the U.S. until October 30, 2020. Grant winners will be announced on December 1, 2020. FUJIFILM Sonosite and the CHEST Foundation expect the research findings to be available by December 2021.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: clinical research, Coronavirus (COVID-19), MD, physicians, point of care, Ultrasound

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |